Company Filing History:
Years Active: 2020-2021
Title: Gallen Triana-Baltzer: Innovator in Neurodegeneration Detection
Introduction
Gallen Triana-Baltzer is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of neurodegeneration detection, holding 2 patents that focus on innovative methods for diagnosing tauopathies.
Latest Patents
His latest patents include groundbreaking assays designed to detect neurodegeneration. These methods involve measuring the amount of singly- or multiply-phosphorylated p217+ tau protein in a sample. The patents also provide methods for detecting or diagnosing tauopathies, determining the effectiveness of treatments for tauopathies, and assessing whether a subject is suitable for anti-p217+ tau antibody therapy. Additionally, the patents describe antibodies for use in these methods and kits that comprise the antibodies.
Career Highlights
Gallen Triana-Baltzer is currently associated with Janssen Pharmaceutica NV, where he continues to advance research in neurodegeneration. His work has been instrumental in developing diagnostic tools that can significantly impact patient care.
Collaborations
He has collaborated with notable colleagues, including Hartmuth C Kolb and John Randall Slemmon, to further enhance the research and development of innovative solutions in his field.
Conclusion
Gallen Triana-Baltzer's contributions to neurodegeneration detection exemplify the importance of innovation in medical research. His patents and ongoing work at Janssen Pharmaceutica NV highlight his commitment to improving diagnostic methods for tauopathies.